Cargando…
Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma
BACKGROUND: DNA-sensing receptor cyclic GMP–AMP synthase (cGAS) and its downstream signaling effector stimulator of interferon genes (STING) present a novel role in anti-tumor immunity. Recently, the combination of cGAS-STING agonists and immunotherapy achieved promising results in some tumor types....
Autores principales: | Zhu, Chao, Li, Jiang, Yao, Mianfeng, Fang, Changyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501566/ https://www.ncbi.nlm.nih.gov/pubmed/34625078 http://dx.doi.org/10.1186/s12903-021-01813-8 |
Ejemplares similares
-
Prognostic Value of an Immune-Related Gene Signature in Oral Squamous Cell Carcinoma
por: Zhu, Chao, et al.
Publicado: (2021) -
Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma
por: Zhu, Chao, et al.
Publicado: (2021) -
HNRNPA2B1, as a m(6)A Reader, Promotes Tumorigenesis and Metastasis of Oral Squamous Cell Carcinoma
por: Zhu, Feiya, et al.
Publicado: (2021) -
A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2019) -
Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022)